Warburg Research set a €89.00 ($103.49) price objective on Symrise (FRA:SY1) in a research report report published on Wednesday, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.
SY1 has been the topic of a number of other reports. Kepler Capital Markets reaffirmed a buy rating and issued a $134.00 target price on shares of Airbus in a research note on Tuesday, April 30th. JPMorgan Chase & Co. set a €50.00 ($58.14) target price on shares of Brenntag and gave the company a buy rating in a research note on Tuesday. Deutsche Bank raised shares of SUN ART RETAIL/ADR from a hold rating to a buy rating in a research note on Wednesday, July 3rd. Barclays reaffirmed a hold rating and issued a $52.00 target price on shares of Biohaven Pharmaceutical in a research note on Tuesday, March 19th. Finally, Morgan Stanley set a $70.00 price target on shares of Edison International and gave the company a hold rating in a research report on Monday, July 15th. Two analysts have rated the stock with a sell rating, twelve have assigned a hold rating and six have given a buy rating to the stock. Symrise has a consensus rating of Hold and an average price target of €79.50 ($92.44).
Shares of SY1 opened at €82.36 ($95.77) on Wednesday. The company has a 50 day moving average of €85.46. Symrise has a 1-year low of €56.96 ($66.23) and a 1-year high of €73.48 ($85.44).
Symrise Company Profile
Symrise AG develops, produces, and sells fragrances, flavorings, and cosmetic ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances.
See Also: Stock Portfolio Tracker
Receive News & Ratings for Symrise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Symrise and related companies with MarketBeat.com's FREE daily email newsletter.